These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 9894977
1. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. Neurosurgery; 1999 Jan; 44(1):163-71; discussion 171-2. PubMed ID: 9894977 [Abstract] [Full Text] [Related]
2. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119 [Abstract] [Full Text] [Related]
3. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ. Stroke; 1999 Sep; 30(9):1891-9. PubMed ID: 10471442 [Abstract] [Full Text] [Related]
4. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen. Zausinger S, Westermaier T, Plesnila N, Steiger HJ, Schmid-Elsaesser R. Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554 [Abstract] [Full Text] [Related]
9. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia. Schöller K, Zausinger S, Baethmann A, Schmid-Elsaesser R. Brain Res; 2004 Oct 15; 1023(2):272-8. PubMed ID: 15374753 [Abstract] [Full Text] [Related]
12. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Westermaier T, Zausinger S, Baethmann A, Schmid-Elsaesser R. Acta Neurochir (Wien); 2005 May 15; 147(5):525-32; discussion 532. PubMed ID: 15838594 [Abstract] [Full Text] [Related]
13. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN). Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ. Exp Brain Res; 2000 Jan 15; 130(1):60-6. PubMed ID: 10638441 [Abstract] [Full Text] [Related]
14. Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome. Smith SL, Hall ED. J Neurotrauma; 1998 Sep 15; 15(9):707-19. PubMed ID: 9753218 [Abstract] [Full Text] [Related]
17. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Bågenholm R, Andiné P, Hagberg H. Pediatr Res; 1996 Sep 15; 40(3):399-403. PubMed ID: 8865275 [Abstract] [Full Text] [Related]
18. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion. Kawaguchi K, Graham SH. Brain Res; 1997 Feb 21; 749(1):131-4. PubMed ID: 9070637 [Abstract] [Full Text] [Related]